Related Experiment Video
Updated: Oct 18, 2025

07:59
Transition of Farm Pigs to Research Pigs using a Designated Checklist followed by Initiation of Clicker Training - a Refinement Initiative
Published on: August 21, 2021
5.7K
Strategies to apply 3Rs in preclinical testing
Susana B Gorzalczany1, Angeles G Rodriguez Basso1
1Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Pharmacology Department, Buenos Aires, Argentina.
Pharmacology Research & Perspectives
|October 5, 2021
Summary
This study explores applying the 3Rs (Replacement, Reduction, Refinement) to animal testing in preclinical research. It details methods for ethical in vivo testing, prioritizing animal welfare and reducing animal use.
Failed At:
2026-06-19T13:28:52.755480+00:00
Related Concept Videos
Preclinical Development: Overview
5.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
201
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
201

